custom image

Genomic Stability and DNA Repair

September 21-23, 2020 | 10:00AM EDT | 2:00PM UTC*
*Program is in development and subject to change

This virtual conference seeks to connect emerging mechanisms of DNA repair and replication with genome stability. The significance and complexity of the DNA damage response cannot be understated, with a central role in reproduction, development, and genome evolution, as highlighted by the many human disease states that occur from genome instability stemming from DNA repair deficiency. The scientific program reflects the importance of classical processes such as DNA replication and homology directed DNA repair in genome integrity, while highlighting emerging aspects of the DNA damage response involving noncoding RNA, chromatin recognition and organization, and catastrophic rearrangements that emanate from mitosis. An additional area of innovation is the realization that genome stability influences human physiology through its signaling to metabolism, the immune system, hematopoietic stem cells, and developmental biology. We will emphasize the importance of fundamental DNA repair mechanisms to organismal biology in normal and pathophysiological states, including opportunities to exploit the DNA damage response for therapeutic gain and genome engineering. The scientific program encompasses two keynote speakers, eight plenary sessions and four workshops, that collectively, represent the most exciting aspects of the field and bring together a scientifically diverse group of international investigators to promulgate interdisciplinary areas of exploration.

Program is intended for scientific researchers and clinical audiences.

Join us for this landmark virtual event, brought to you by Keystone Symposia.


Registration for this meeting is now closed.


Scholarships: Passed
Abstract Submission: Passed


Program Details

Speaking at this eSymposia

Mirit Aladjem

NCI, National Institutes of Health, USA

Simon J. Boulton

Francis Crick Institute, UK

J. Ross Chapman

University of Oxford, UK

Irene Chiolo

University of Southern California, USA

Dipanjan Chowdhury

Dana-Farber Cancer Institute, Harvard Medical School, USA

Karlene A. Cimprich

Stanford University, USA

David Cortez

Vanderbilt University School of Medicine, USA

Alan D. D'Andrea

Dana-Farber Cancer Institute, USA

Titia de Lange

Rockefeller University, USA

Daniel Durocher

Lunenfeld-Tanenbaum Research Institute, Canada

Anindya Dutta

University of Virginia, USA

Roger Greenberg

University of Pennsylvania, USA

Jacqueline J. Jacobs

Netherlands Cancer Institute, Netherlands

Maria Jasin

Memorial Sloan Kettering Cancer Center, USA

Gaelle Legube

Center for Integrative Biology, France

Joachim Lingner

École Polytechnique Fédérale de Lausanne, Switzerland

Nima Mosammaparast

Washington University in St. Louis, USA

André Nussenzweig

NCI, National Institutes of Health, USA

David Pellman

Dana-Farber Cancer Institute, USA

Katharina Schlacher

MD Anderson Cancer Center, USA

Barry P. Sleckman

University of Alabama Birmingham School of Medicine, USA

Patrick M. Sung

University of Texas Health Science Center at San Antonio, USA

Lorraine S. Symington

Columbia University, USA

Madalena Tarsounas

University of Oxford, UK

Helle D. Ulrich

Institute of Molecular Biology, Germany

Lee Zou

Harvard Medical School, USA



custom image


Additional Support


custom image


Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation

Media In-Kind Sponsors




custom image

The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.

Donate to Keystone Symposia

custom image